Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study

被引:0
|
作者
Taha, Ahmed E. [1 ,2 ]
Amer, Ibrahim [3 ]
El Sharawy, Shimaa [4 ]
Ghazy, Amany A. [1 ]
机构
[1] Jouf Univ, Coll Med, Dept Pathol, Microbiol & Immunol Unit, Sakaka 72388, Saudi Arabia
[2] Mansoura Univ, Fac Med, Med Microbiol & Immunol Dept, Mansoura 35516, Egypt
[3] Kafr Elsheikh Univ, Fac Med, Dept Hepatol Gastroenterol & Infect Dis, Kafr Al Sheikh 33516, Egypt
[4] Tanta Univ, Fac Med, Dept Trop Med & Infect Dis, Tanta 31527, Egypt
来源
VIRUSES-BASEL | 2025年 / 17卷 / 03期
关键词
COVID-19; healthy; immunization; SARS-CoV-2; serological testing; vaccines; viruses; IMMUNE-RESPONSE; COVID-19; OBESITY; ANTIBODIES;
D O I
10.3390/v17030378
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is essential to comprehend the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its vaccines to maximize the effectiveness of anti-SARSCoV-2 community immunization efforts. The aim of this cross-sectional study was to determine the seroprevalence of anti-SARS-CoV-2 IgM/IgG among newcomer students at Kafr Elsheikh University in Egypt, whether they had been vaccinated or not. Blood samples from 400 healthy newcomer students (200 non-vaccinated and 200 vaccinated) were evaluated for the presence of anti-SARS-CoV-2 IgM/IgG using colloidal gold immunochromatography lateral flow immunoassay cards, and then the results were confirmed by using specific ELISA tests. The prevalence of anti-SARS-CoV-2 antibodies among the participants (n = 400) was 56.3% for IgG and 13.3% for IgM. Regarding the non-vaccinated participants, 55.0% were females, the mean age was 18.2 years, and the mean BMI was 25.35. Regarding the vaccinated participants, 58.5% were females, the mean age was 18.1 years, and the mean BMI was 25.3. There were statistically non-significant correlations (p > 0.05) between gender, BMI, and each of IgM- or IgG-positivity in both vaccinated and non-vaccinated groups. In total, 41.5% and 48.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were non-vaccinated, respectively. Furthermore, 58.5% and 51.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were vaccinated, respectively. No statistically significant association (p > 0.05) in immunoglobulins positivity between the anti-SARS-CoV-2 non-vaccinated, and vaccinated groups. The anti-SARS-CoV-2 immunological response of nonsmokers, people who exercise regularly, and those who take vitamin supplements, eat a balanced diet, and use certain herbs is noteworthy. Among the vaccinated subjects, 96.6%, 25.0%, 31.9%, 45.7%, and 7.8% of the IgG-positive group, versus 97.2%, 60.6%, 64.2%, 52.3%, and 6.4% of the IgG-positive non-vaccinated group, were nonsmokers, exercisers, and those taking vitamin supplements, eating a balanced diet, and using herbs, respectively. Furthermore, 93.5%, 32.3%, 35.5%, 48.4%, and 6.5% of the IgM-positive vaccinated group, versus 100.0%, 63.6%, 81.8%, 45.5%, and 4.5% of the IgM-positive non-vaccinated participants, were nonsmokers, physical exercisers, vitamin supplement users, balanced eaters, and herbalists, respectively. Persons who are free from comorbidities, young, non-obese, non-smokers, engage in physical exercise, take vitamins, eat a balanced diet, and use certain immunostimulant herbal supplements, all have a strong anti-SARS-CoV-2 humoral immune response, even if they were not vaccinated. During pandemics, vaccination of this group should not be a priority to preserve vaccine doses for high-risk vulnerable people. Even if there is a lockdown during an anticipated future epidemic or pandemic, we should prioritize healthy eating and lifestyle choices, along with increasing physical activity.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Assessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses — fall 2021, Wisconsin
    Peter M. DeJonge
    Anastasia S. Lambrou
    Hannah E. Segaloff
    Allen Bateman
    Alana Sterkel
    Carol Griggs
    Jake Baggott
    Patrick Kelly
    Natalie Thornburg
    Monica Epperson
    Rodel Desamu-Thorpe
    Glen Abedi
    Christopher H. Hsu
    Jasmine Y. Nakayama
    Jasmine Ruffin
    Darlene Turner-Harper
    Almea Matanock
    Olivia Almendares
    Melissa Whaley
    Ayan Chakrabarti
    Kyle DeGruy
    Michele Daly
    Ryan Westergaard
    Jacqueline E. Tate
    Hannah L. Kirking
    BMC Infectious Diseases, 23
  • [32] SARS-CoV-2 antibody seroprevalence rates among Egyptian blood donors around the third wave: Cross-sectional study
    Eldesoukey, Nermeen
    Gaafar, Taghrid
    Enein, Azza Aboul
    Eyada, Iman
    Khirat, Sahar
    ElShahawy, Asmaa
    Diaa, Nehal
    Youssry, Ilham
    HEALTH SCIENCE REPORTS, 2022, 5 (03)
  • [33] Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
    He, Zhenyu
    Ren, Lili
    Yang, Juntao
    Guo, Li
    Feng, Luzhao
    Ma, Chao
    Wang, Xia
    Leng, Zhiwei
    Tong, Xunliang
    Zhou, Wang
    Wang, Geng
    Zhang, Ting
    Guo, Yan
    Wu, Chao
    Wang, Qing
    Liu, Manqing
    Wang, Conghui
    Jia, Mengmeng
    Hu, Xuejiao
    Wang, Ying
    Zhang, Xingxing
    Hu, Rong
    Zhong, Jingchuan
    Yang, Jin
    Dai, Juan
    Chen, Lan
    Zhou, Xiaoqi
    Wang, Jianwei
    Yang, Weizhong
    Wang, Chen
    LANCET, 2021, 397 (10279): : 1075 - 1084
  • [34] Dynamic changes of SARS-CoV-2 specific IgM and IgG among population vaccinated with COVID-19 vaccine
    Chen, Fengling
    Zhong, Yi
    Li, Jiazhao
    Luo, Jianrong
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [35] Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
    Raouf, May
    Rabeh, Mariem
    Kaur, Suminder
    Sharma, Ranjita
    Thottumkal, Nimmy
    Mohammed, Roukaya
    DUBAI MEDICAL JOURNAL, 2021, 4 (03): : 204 - 211
  • [36] SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study
    Sass, Marie Reeberg
    Juul, Tobias Sogaard
    Skov, Robert
    Iversen, Kasper
    Harritshoj, Lene Holm
    Sorensen, Erik
    Ostrowski, Sisse Rye
    Andersen, Ove
    Ekstrom, Claus Thorn
    Ullum, Henrik
    Nielsen, Jimmi
    Hageman, Ida
    Fink-Jensen, Anders
    PLOS ONE, 2022, 17 (03):
  • [37] Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
    Guzijan, Gordana
    Marisavljevic, Dragomir
    Milosavic, Milanka
    Srzentic, Snezana Jovanovic
    VOJNOSANITETSKI PREGLED, 2021, 78 (06) : 691 - 692
  • [38] EFFECTS OF OBSTRUCTIVE SLEEP APNEA ON ANTI-SARS-COV-2 IGG LEVELS IN OLDER ADULTS VACCINATED AGAINST COVID-19
    Pires, Gabriel
    Andersen, Monica
    Rosa, Daniela
    Tufik, Sergio
    Tufik, Sergio
    SLEEP, 2022, 45 : A310 - A310
  • [39] Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020
    Cowgill, Karen D.
    Erosheva, Elena A.
    Elder, Adam
    Miljacic, Ljubomir
    Buskin, Susan
    Duchin, Jeffrey S.
    PLOS ONE, 2022, 17 (08):
  • [40] Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study
    Khan, S. Muhammad Salim
    Qurieshi, Mariya Amin
    Haq, Inaamul
    Majid, Sabhiya
    Bhat, Arif Akbar
    Nabi, Sahila
    Ganai, Nisar Ahmad
    Zahoor, Nazia
    Nisar, Auqfeen
    Chowdri, Iqra Nisar
    Qazi, Tanzeela Bashir
    Kousar, Rafiya
    Lone, Abdul Aziz
    Sabah, Iram
    Nabi, Shahroz
    Sumji, Ishtiyaq Ahmad
    Kawoosa, Misbah Ferooz
    Ayoub, Shifana
    PLOS ONE, 2020, 15 (11):